Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

The Plant Medicine Week Being Held At A Heritage Venue In Malta Hosting Industry Leading Professionals

The Microdose Plant Medicine Week will be held on April 5-8th 2022, at the Mediterranean Conference Centre, one of the finest heritage buildings of Valletta, Malta. The Centre is a landmark venue having membership of the prestigious Historic Conference Centres of Europe (“HCCE”). Investors, entrepreneurs, psychedelic and cannabis researchers, policymakers, and professionals from the health, […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Multiple Strong Market Paths

Lexaria is a global innovator that has developed the patented DehydraTECH(TM) technology that improves bioavailability, speed of onset, and brain absorption of active pharmaceutical ingredients (“APIs”) The company strategically partners with third-party organizations seeking to explore formulation opportunities with their specific APIs Lexaria is evaluating the effectiveness of various DehydraTECH-processed APIs, including CBD, nicotine, sildenafil, […]

LiDARs have been one of key enablers for autonomous vehicle sector, but this unique technology offers use cases beyond automotive industry Consumer Electronics Show, one of the world’s most influential tech events, demonstrates that LiDAR is growing within non-automotive landscape, including smart city/infrastructure and security Cepton set to benefit as the Company has already established […]

InnerScope Hearing Technologies Inc. (INND) Seeks to Position for the Launch of the OTC Hearing Aid Law; Inks Agreement with RiteAid.Com

InnerScope Hearing Technologies recently announced that subsidiary HearingAssist’s products would be carried by RiteAid.com The distribution agreement with one of the nation’s leading drug store chains comes as InnerScope seeks to position itself to benefit from the upcoming OTC Hearing Aid Law The Hearing Aid Law will create a new category of hearing aids, available […]

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Begins Recruitment for Study Measuring Ketamine’s Psychedelic Effect

Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics into therapeutics. Cybin’s (NEO: CYBN) (NYSE American: CYBN) efforts to transform the mental-health treatment landscape have reached a key […]

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Leveraging Growth Across Multiple Markets Including Mental Health, Healthcare IT

Mydecine was founded in 2020 as a response to the lack of innovation addressing mental health treatment and the therapeutic possibilities represented by psychedelic compounds and other novel molecules The world is experiencing a shortage of mental health resources, while faced with an increase in mental health issues on the heels of the pandemic Mydecine […]

Correlate Infrastructure Partners Inc. (TCCR) Building Climate Change Solutions Through Utilities Analysis for Commercial Facilities

Correlate Infrastructure Partners is a provider of data analysis and scalable services to help commercial and industrial real estate owners meet carbon reduction goals while also improving their net operating income Carbon reduction is a significant part of the multi-national response to climate change concerns, and Correlate Infrastructure Partners is taking a site-specific approach to […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.